5L
ABBV icon

55I LLC’s AbbVie ABBV Stock Holding History

55I LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$4.24M Buy
31,569
+21,245
+206% +$3.05M 0.12% 112
2022
Q2 		$1.58M Buy
10,324
+3,406
+49% +$520K 0.04% 195
2022
Q1 		$1.12M Buy
6,918
+676
+11% +$98.2K 0.03% 247
2021
Q4 		$844K Sell
6,242
-4,190
-40% -$495K 0.02% 272
2021
Q3 		$1.13M Buy
10,432
+5,216
+100% +$596K 0.03% 217
2021
Q2 		$588K Buy
5,216
+1,370
+36% +$154K 0.02% 238
2021
Q1 		$416K Buy
+3,846
New +$411K 0.02% 221

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

55I LLC's ABBV Position: Q3 2022 in Review

55I LLC increased its AbbVie (ABBV) stake by 206% in Q3 2022, buying an estimated $3.05M and bringing the position to 31,569 shares worth $4.24M. The position accounts for 0.12% of the portfolio, ranked #112.

55I LLC first reported a position in ABBV in Q1 2021 and has held it in 7 quarters since. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • 55I LLC held 31,569 shares of AbbVie worth $4.24M as of Q3 2022.
  • 55I LLC bought 21,245 AbbVie shares in Q3 2022, an estimated $3.05M.
  • AbbVie made up 0.12% of 55I LLC's portfolio in Q3 2022, its #112 holding.
  • 55I LLC first reported a position in AbbVie in Q1 2021 and has held it in 7 quarters since.
  • 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on 55I LLC's 13F filing for Q3 2022, filed 14 Nov 2022.